Concepedia

Author

Yinjun Dong

Shandong First Medical University

Also Known As

Yinjun Dong

13

Publications

202

Citations

9

H-Index

13

Concepts

All Affiliations

Shandong First Medical UniversityShandong Tumor HospitalShandong UniversitySun Yat-sen UniversityLiaocheng People's Hospital
YD

About

Yinjun Dong is an author at Shandong First Medical University specializing in oncology, radiology, and nuclear medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

2

2

47

2

Engineering

1

1

30

3

Medicine

1

1

17

4

Pathology

1

1

17

5

Molecular Imaging

1

1

30

Yinjun Dong

×

8

Publications

187

Citations

8

H-Index

YearCitations

A Pilot Study of 18F-Alfatide PET/CT Imaging for Detecting Lymph Node Metastases in Patients with Non-Small Cell Lung Cancer

Yue Zhou, Song Gao, Yong Huang,

Scientific Reports

2017

31

CT-Based Hand-crafted Radiomic Signatures Can Predict PD-L1 Expression Levels in Non-small Cell Lung Cancer: a Two-Center Study

Zekun Jiang, Yinjun Dong, Linke Yang,

Journal of Digital Imaging

2021

30

Development and validation of novel radiomics-based nomograms for the prediction of EGFR mutations and Ki-67 proliferation index in non-small cell lung cancer

Yinjun Dong, Zekun Jiang, Chaowei Li,

Quantitative Imaging in Medicine and Surgery

2022

29

Combined inflammatory parameters and tertiary lymphoid structure predict prognosis in patients with resectable non-small cell lung cancer treated with neoadjuvant chemoimmunotherapy

Fuhao Xu, He Zhu, Yinjun Dong,

Frontiers in Immunology

2023

28

Model integrating CT-based radiomics and genomics for survival prediction in esophageal cancer patients receiving definitive chemoradiotherapy

Jinfeng Cui, Li Li, Ning Liu,

Biomarker Research

2023

27

Relationship Between Clinicopathological Characteristics and PET/CT Uptake in Esophageal Squamous Cell Carcinoma: [18F]Alfatide versus [18F]FDG

Yinjun Dong, Yuchun Wei, Guanxuan Chen,

Molecular Imaging and Biology

2018

17

Tertiary lymphoid structures combined with biomarkers of inflammation are associated with the efficacy of neoadjuvant immunochemotherapy in resectable non‐small cell lung cancer: A retrospective study

Fuhao Xu, He Zhu, Dali Xiong,

Thoracic Cancer

2023

13

[Retracted] Homeobox A1 Facilitates Immune Escape and Alleviates Oxidative Stress in Lung Adenocarcinoma

Fen Zhao, Hui Tian, Xinchao Liu,

Oxidative Medicine and Cellular Longevity

2022

12

Page 1